REGULATORY

• Chuikyo Wary about Off-Year Price Survey amid COVID-19, Industry Officials Stress Concerns
  May 28, 2020

• Japan Drops May-End Goal for Avigan’s COVID-19 Approval
  May 27, 2020

• Council to Discuss Medical Needs for Additional Indications for Antiemetics Ondansetron, Granisetron
  May 27, 2020

• Japan’s First Humalog Biosimilar to Join NHI Price List on May 27
  May 26, 2020

• Final Report from Govt’s All-Generation Social Security Council to Be Delayed until Year-End
  May 26, 2020

• June Approval Likely for Entresto as It Clears Key Panel; HFpEF Use OK’ed Too
  May 25, 2020

• Panel OKs Ofev for PF-ILD; Label Expansion for Xtandi/Erleada, Prevenar and More
  May 25, 2020

• MSD’s 9-Valent HPV Vaccine Now in Line for June Approval; Eyes on Its Possible Inclusion in National Immunization Program
  May 25, 2020

• PMDA Reviewing Safety Risks for Avastin, Memary
  May 25, 2020

• AMED to Fund 4 Company-Led COVID-19 Vaccine Development Projects
  May 25, 2020

• Avigan Not Yet Filed in Japan, but Govt Still Seeks Approval by Month-End: Kato
  May 25, 2020

• Add MSD’s 9-Valent HPV Vaccine to National Immunization Program If Approved: Lawmakers
  May 21, 2020

• Label Revisions Ordered for 15 Insulins, Erleada, Faslodex
  May 20, 2020

• MHLW Adds Veklury in Updated COVID-19 Treatment Guide
  May 20, 2020

• LDP Lawmakers Call for Environment to Facilitate Vaccine Development
  May 20, 2020

• Check Latest Info and Make Careful Decision on Veklury Use: PMDA Review Report
  May 19, 2020

• MHLW Panel to Discuss HIF-PH Inhibitors from GSK, Mitsubishi Tanabe on May 29
  May 19, 2020

• MHLW Panel to Discuss Orphan Status for 5 Cell and Gene Products
  May 19, 2020

• Health Ministers of Japan, China, South Korea Commit to Support WHO on COVID-19, Timely Share Info
  May 19, 2020

• Govt Won't Require Fujifilm-Sponsored Trial Data to Approve Avigan for COVID-19: Abe
  May 18, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• …
• Next ›
• 最終 »